ArrowMark Colorado Holdings’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

ArrowMark Colorado Holdings’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-44,080	Closed	-$2.65M	–	347
2020 Q2	$2.65M	Sell	44,080 -104,751	-70%	-$9.6M	0.03%	217
2020 Q1	$11.2M	Buy	148,831 +17,971	+14%	+$2.07M	0.15%	119
2019 Q4	$18M	Buy	130,860 +47,617	+57%	+$5.79M	0.16%	120
2019 Q3	$9.89M	Buy	83,243 +11,860	+17%	+$1.66M	0.1%	155
2019 Q2	$9.99M	Buy	71,383 +124	+0.2%	+$21.8K	0.1%	170
2019 Q1	$12.7M	Buy	71,259 +6,985	+11%	+$1.05M	0.12%	147
2018 Q4	$10.1M	Buy	+64,274	New	+$9.58M	0.11%	173

Other funds holding ORTX

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

ArrowMark Colorado Holdings's ORTX Position: Q3 2020 in Review

ArrowMark Colorado Holdings sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q3 2020, closing a stake of 44,080 shares — an estimated $2.65M sold.

ArrowMark Colorado Holdings first reported a position in ORTX in Q4 2018 and held it in 7 quarters. The position peaked at $18M in Q4 2019. 72 funds tracked by Wall St. Rank hold ORTX as of Q3 2020.

ArrowMark Colorado Holdings reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q3 2020 after selling out during the quarter.
ArrowMark Colorado Holdings sold 44,080 Orchard Therapeutics plc American Depositary Shares shares in Q3 2020, an estimated $2.65M.
ArrowMark Colorado Holdings first reported a position in Orchard Therapeutics plc American Depositary Shares in Q4 2018 and held it in 7 quarters.
ArrowMark Colorado Holdings's Orchard Therapeutics plc American Depositary Shares position peaked at $18M in Q4 2019.
72 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q3 2020.

Based on ArrowMark Colorado Holdings's 13F filing for Q3 2020, filed 16 Nov 2020.